Published in J Clin Invest on December 01, 2003
Adiposity and Airway Inflammation in HIV-Associated Airway Disease (SHOP) | NCT02975258
Impact of Ageing on Adipose, Muscle and Systemic Inflammation | NCT02777138
Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL) (EIFFEL) | NCT01745471
Effectiveness of Dapagliflozin for Weight Loss | NCT03968224
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49
Inflammation, stress, and diabetes. J Clin Invest (2005) 17.11
Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 13.44
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest (2004) 13.42
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 12.32
Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature (2007) 11.59
CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med (2009) 11.28
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med (2005) 10.88
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 9.71
Adipocytes as regulators of energy balance and glucose homeostasis. Nature (2006) 9.52
Adipokines in inflammation and metabolic disease. Nat Rev Immunol (2011) 8.92
Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest (2007) 8.71
GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell (2010) 8.69
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol (2008) 8.43
Type 2 diabetes as an inflammatory disease. Nat Rev Immunol (2011) 8.30
Macrophage biology in development, homeostasis and disease. Nature (2013) 8.28
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med (2011) 8.00
Obesity-induced inflammatory changes in adipose tissue. J Clin Invest (2003) 7.50
Mechanisms for insulin resistance: common threads and missing links. Cell (2012) 6.85
Inflammatory links between obesity and metabolic disease. J Clin Invest (2011) 6.73
Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest (2008) 6.60
Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev (2007) 6.53
Adipose tissue remodeling and obesity. J Clin Invest (2011) 6.12
Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab (2008) 5.83
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov (2008) 5.78
The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med (2012) 5.63
Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab (2008) 5.53
Trophic macrophages in development and disease. Nat Rev Immunol (2009) 5.37
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology (2010) 5.35
The metabolic syndrome. Endocr Rev (2008) 5.33
A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science (2008) 5.28
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med (2011) 5.16
Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab (2008) 5.10
Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab (2008) 5.07
Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab (2009) 5.02
Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest (2007) 4.86
Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol (2008) 4.75
Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity. Circulation (2009) 4.71
Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol (2011) 4.68
Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest (2010) 4.56
A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome Res (2008) 4.33
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell (2005) 4.30
Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest (2011) 4.17
Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science (2010) 4.15
Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev (2008) 4.14
What we talk about when we talk about fat. Cell (2014) 4.12
NF-κB, inflammation, and metabolic disease. Cell Metab (2011) 4.00
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med (2009) 3.97
Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol (2009) 3.96
Autophagy regulates adipose mass and differentiation in mice. J Clin Invest (2009) 3.95
The protein kinase IKKepsilon regulates energy balance in obese mice. Cell (2009) 3.93
PPAR gamma and human metabolic disease. J Clin Invest (2006) 3.83
Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes (2008) 3.80
Molecular mechanisms of cancer development in obesity. Nat Rev Cancer (2011) 3.65
MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab (2009) 3.64
Alternative macrophage activation and metabolism. Annu Rev Pathol (2011) 3.59
Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res (2008) 3.47
Inflammation and insulin resistance. FEBS Lett (2007) 3.34
Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol (2006) 3.31
Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes (2009) 3.27
Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell (2014) 3.22
Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) (2008) 3.17
An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice. Nat Med (2013) 3.15
JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science (2012) 3.12
The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab (2010) 3.11
Inflamed fat: what starts the fire? J Clin Invest (2006) 3.11
Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab (2008) 3.11
Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab (2009) 3.10
Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol (2009) 3.09
Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab (2006) 3.04
MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes (2009) 3.02
Retracted Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol (2011) 3.02
Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab (2013) 3.00
Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (Phila) (2011) 2.97
Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab (2012) 2.96
Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res (2010) 2.96
Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A (2011) 2.92
PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet (2007) 2.91
Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis (2008) 2.89
Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science (2013) 2.85
Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology (2006) 2.82
Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol (2008) 2.82
Diacylglycerol-mediated insulin resistance. Nat Med (2010) 2.82
Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest (2007) 2.81
Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity (2012) 2.80
In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest (2008) 2.78
Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet--induced obesity in mice. Diabetes (2010) 2.76
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature (2013) 2.74
Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest (2007) 2.73
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol (2008) 2.73
Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci U S A (2008) 2.71
Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta (2008) 2.67
Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes (2011) 2.67
A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med (2009) 2.65
Obesity and free fatty acids. Endocrinol Metab Clin North Am (2008) 2.64
High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One (2010) 2.60
Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol (2000) 128.08
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun (1999) 14.25
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature (1998) 13.58
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature (1997) 10.53
From patterns to pathways: gene expression data analysis comes of age. Nat Genet (2002) 10.35
PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature (1998) 10.09
Elevated C-reactive protein levels in overweight and obese adults. JAMA (1999) 9.94
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature (1990) 8.94
Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest (1997) 7.58
Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab (1998) 7.05
Changes in energy expenditure resulting from altered body weight. N Engl J Med (1995) 7.03
Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med (1998) 6.52
PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med (2001) 6.09
Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A (2003) 6.06
CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem (1993) 5.81
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med (2001) 5.74
Is type II diabetes mellitus a disease of the innate immune system? Diabetologia (1998) 5.43
PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes (2001) 5.18
Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A (1990) 5.05
Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev (2000) 4.57
Molecular characterization of the mouse agouti locus. Cell (1992) 4.55
Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab (1997) 4.47
Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med (2002) 4.47
Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A (2002) 4.40
Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A (1994) 4.08
Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem (2003) 3.91
Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development (1994) 3.86
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest (2001) 3.64
Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia (2000) 3.63
Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci U S A (1995) 3.33
A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med (2002) 3.22
Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest (1995) 3.18
Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med (2001) 3.14
Body mass index and the risk of stroke in men. Arch Intern Med (2002) 2.90
Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab (2002) 2.76
The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest (1996) 2.73
Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity. Genes Dev (1993) 2.68
Biology and action of colony--stimulating factor-1. Mol Reprod Dev (1997) 2.52
Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism. Mol Cell Biol (2002) 2.44
Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. J Biol Chem (1988) 2.40
The molecular genetics of rodent single gene obesities. J Biol Chem (1997) 2.32
Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. Am J Physiol Regul Integr Comp Physiol (2003) 2.28
A role for preadipocytes as macrophage-like cells. FASEB J (1999) 2.24
Macrophages are necessary for maximal nuclear factor-kappa B activation in response to endotoxin. Am J Respir Cell Mol Biol (2002) 2.05
The macrophage. Bioessays (1995) 2.01
Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes (2002) 2.00
Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol (1990) 1.94
Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med (1997) 1.92
Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA (2002) 1.83
Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology (1995) 1.77
The effect of insulin upon glucose metabolism by adipose cells of different size. Influence of cell lipid and protein content, age, and nutritional state. J Clin Invest (1971) 1.77
Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. J Biol Chem (2001) 1.74
Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem (2003) 1.73
Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes (1997) 1.72
The role of the macrophage in immune regulation. Res Immunol (1999) 1.65
Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. J Clin Invest (1996) 1.65
Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun (2003) 1.65
Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults. Lancet (1972) 1.61
Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis (2002) 1.60
Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Diabetes (2001) 1.60
Peroxisome proliferator-activated receptor-gamma in macrophage lipid homeostasis. Trends Endocrinol Metab (2002) 1.58
Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-alpha. Diabetes (2000) 1.58
Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1. Blood (2003) 1.57
The role of leptin in human physiology. N Engl J Med (1999) 1.55
Mechanism of insulin-resistant glucose transport activity in the enlarged adipose cell of the aged, obese rat. J Clin Invest (1982) 1.51
Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J Clin Invest (1998) 1.51
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med (1981) 1.48
Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma. J Leukoc Biol (2002) 1.47
Determinants of leptin gene expression in fat depots of lean mice. Am J Physiol Regul Integr Comp Physiol (2002) 1.45
Tissue factor gene expression in the adipose tissues of obese mice. Proc Natl Acad Sci U S A (1998) 1.44
Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes (2000) 1.43
Altered macrophage-like functions of preadipocytes in inflammation and genetic obesity. J Cell Physiol (2001) 1.41
Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord (1999) 1.39
Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30, > or =30). Am J Cardiol (2002) 1.38
Genetic models of obesity and energy balance in the mouse. Annu Rev Genet (2000) 1.37
Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. J Clin Endocrinol Metab (1987) 1.37
Excess abdominal adiposity remains correlated with altered lipid concentrations in healthy older women. Int J Obes Relat Metab Disord (1999) 1.34
Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21--q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol Genet Metab (2001) 1.32
Coagulation and fibrinolysis abnormalities in obesity. J Endocrinol Invest (2002) 1.29
Ultrasound measurements of intraabdominal fat estimate the metabolic syndrome better than do measurements of waist circumference. Am J Clin Nutr (2003) 1.28
Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines. Arthritis Res (2001) 1.27
Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1. Am J Pathol (2003) 1.25
Body fat distribution and cardiovascular risk in normal weight women. Associations with insulin resistance, lipids and plasma leptin. Int J Obes Relat Metab Disord (2000) 1.24
Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment. Invest Ophthalmol Vis Sci (1999) 1.22
Alveolar macrophage kinetics and multinucleated giant cell formation after lung injury. J Leukoc Biol (1996) 1.18
Effects of altered adipose tissue morphology on plasma insulin levels in the rat. Am J Physiol (1981) 1.16
Body composition and adipose tissue cellularity before and after jejuno-ileostomy in severely obese subjects. Eur J Clin Invest (1977) 1.15
Weight change and blood coagulability and fibrinolysis in healthy obese women. Int J Obes Relat Metab Disord (2001) 1.13
Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature (2007) 11.59
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44
Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab (2008) 5.83
The long-term stability of the human gut microbiota. Science (2013) 5.15
Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest (2010) 4.56
Human oocytes reprogram somatic cells to a pluripotent state. Nature (2011) 4.03
Estimating the changes in energy flux that characterize the rise in obesity prevalence. Am J Clin Nutr (2009) 3.56
Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol (2008) 3.49
Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A (2009) 3.43
Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med (2013) 3.41
Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest (2005) 3.10
Optical biopsy of sessile serrated adenomas: do these lesions resemble hyperplastic polyps under narrow-band imaging? Gastrointest Endosc (2013) 2.80
Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab (2010) 2.79
Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab (2002) 2.76
Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell (2012) 2.46
Functional analyses of variants reveal a significant role for dominant negative and common alleles in oligogenic Bardet-Biedl syndrome. Proc Natl Acad Sci U S A (2010) 2.45
Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest (2008) 2.44
Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. Am J Physiol Regul Integr Comp Physiol (2003) 2.28
Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab (2013) 2.23
Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999-2010. Am J Epidemiol (2013) 2.20
Is the energy homeostasis system inherently biased toward weight gain? Diabetes (2003) 2.14
Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer (2013) 2.14
Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr (2008) 2.13
NIH working group report: Innovative research to improve maintenance of weight loss. Obesity (Silver Spring) (2014) 2.08
11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med (2009) 1.99
Waist Circumference and Cardiometabolic Risk: a Consensus Statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring) (2007) 1.87
C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes (2010) 1.86
Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol (2008) 1.83
Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring) (2011) 1.73
To eat or not to eat - how the gut talks to the brain. N Engl J Med (2003) 1.68
The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy. BJU Int (2009) 1.55
A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children. J Clin Invest (2011) 1.55
Reprogramming within hours following nuclear transfer into mouse but not human zygotes. Nat Commun (2011) 1.49
Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review. PLoS One (2013) 1.49
Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy. Urology (2009) 1.48
Significant change in predicted risk of biochemical recurrence after radical prostatectomy more common in black than in white men. Urology (2009) 1.47
Dietary fat is not a major determinant of body fat. Am J Med (2002) 1.46
Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab (2008) 1.45
Determinants of leptin gene expression in fat depots of lean mice. Am J Physiol Regul Integr Comp Physiol (2002) 1.45
Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev (2009) 1.44
Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) (2009) 1.44
Relationship between energy balance and complications after subarachnoid hemorrhage. JPEN J Parenter Enteral Nutr (2009) 1.43
Vitamin D levels and menopause-related symptoms. Menopause (2014) 1.41
Enuresis - children's predictions of their treatment's progress and outcomes. J Clin Nurs (2012) 1.38
Validation of reported predialysis nephrology care of older patients initiating dialysis. J Am Soc Nephrol (2012) 1.36
Body fat redistribution after weight gain in women with anorexia nervosa. Am J Clin Nutr (2005) 1.34
Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia. Environ Health Perspect (2004) 1.32
Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes (2008) 1.29
Real-time optical biopsy of colon polyps with narrow band imaging in community practice does not yet meet key thresholds for clinical decisions. Gastroenterology (2012) 1.28
Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients. J Am Soc Nephrol (2012) 1.27
Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys. Am J Physiol Endocrinol Metab (2006) 1.27
Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. J Biol Chem (2010) 1.26
iPSC-derived β cells model diabetes due to glucokinase deficiency. J Clin Invest (2013) 1.23
Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.23
Energy intake in weight-reduced humans. Brain Res (2010) 1.21
Challenges and opportunities of defining clinical leptin resistance. Cell Metab (2012) 1.21
Leptin reverses declines in satiation in weight-reduced obese humans. Am J Clin Nutr (2012) 1.19
β-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome. Diabetes (2013) 1.19
Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss. Metabolism (2011) 1.17
Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice. Am J Physiol Regul Integr Comp Physiol (2004) 1.17
Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol (2011) 1.17
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis. Cancer Chemother Pharmacol (2007) 1.16
Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine. J Endocrinol (2008) 1.13
Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis. Circulation (2011) 1.12
Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects. Am J Physiol Regul Integr Comp Physiol (2009) 1.12
Absence epilepsy in apathetic, a spontaneous mutant mouse lacking the h channel subunit, HCN2. Neurobiol Dis (2008) 1.12
Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors. Clin Cancer Res (2006) 1.12
Positional cloning of "Lisch-Like", a candidate modifier of susceptibility to type 2 diabetes in mice. PLoS Genet (2008) 1.10
Obesity, inflammation, and macrophages. Nestle Nutr Workshop Ser Pediatr Program (2009) 1.08
Effectiveness of academic detailing on breast cancer screening among primary care physicians in an underserved community. J Am Board Fam Med (2006) 1.07
Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project. Cancer (2009) 1.07
Periodontal infection, systemic inflammation, and insulin resistance: results from the continuous National Health and Nutrition Examination Survey (NHANES) 1999-2004. Diabetes Care (2012) 1.05
Breast cancer treatment across health care systems: linking electronic medical records and state registry data to enable outcomes research. Cancer (2013) 1.05
Reproducibility and accuracy of body composition assessments in mice by dual energy x-ray absorptiometry and time domain nuclear magnetic resonance. Int J Body Compos Res (2009) 1.03
Implementing academic detailing for breast cancer screening in underserved communities. Implement Sci (2007) 1.03
Natural history and clinical outcome of sporadic renal cortical tumors diagnosed in the young adult. Urology (2004) 1.01
Effects of ambient temperature on adaptive thermogenesis during maintenance of reduced body weight in mice. Am J Physiol Regul Integr Comp Physiol (2012) 1.01
Barriers to adherence to cystic fibrosis infection control guidelines. Pediatr Pulmonol (2008) 1.01
Quantitative trait locus mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice: identification of a locus for metabolic syndrome and increased atherosclerosis on chromosome 4. Arterioscler Thromb Vasc Biol (2004) 1.00
Considerations regarding the genetics of obesity. Obesity (Silver Spring) (2008) 1.00
Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant (2012) 0.99
The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein. J Clin Invest (2002) 0.97
Effects of weight loss and leptin on skeletal muscle in human subjects. Am J Physiol Regul Integr Comp Physiol (2011) 0.97
Impracticality of egg donor recruitment in the absence of compensation. Cell Stem Cell (2011) 0.96
In silico mutagenesis: a case study of the melanocortin 4 receptor. FASEB J (2009) 0.96
Functional consequences of the human leptin receptor (LEPR) Q223R transversion. Obesity (Silver Spring) (2008) 0.96
Respective contributions of maternal insulin resistance and diet to metabolic and hypothalamic phenotypes of progeny. Obesity (Silver Spring) (2010) 0.96
Is Hispanic race an important predictor of treatment failure following radical prostatectomy for prostate cancer? J Urol (2004) 0.95
Piecewise exponential models to assess the influence of job-specific experience on the hazard of acute injury for hourly factory workers. BMC Med Res Methodol (2013) 0.95
Kidney function and long-term medication adherence after myocardial infarction in the elderly. Clin J Am Soc Nephrol (2011) 0.95
Inhibition of BCL2 expression and activity increases H460 sensitivity to the growth inhibitory effects of polyphenon E. J Exp Ther Oncol (2009) 0.94
The role of vitamin D and SLCO1B1*5 gene polymorphism in statin-associated myalgias. Dermatoendocrinol (2010) 0.94